{"transactions":[{"id":1637595,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":94207,"kind":"person","name":"Clark David J","position":1,"cik":"0001662693","reported_name":"Clark David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-16T21:43:32.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 15, 2024. The 175,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 15, 2025 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 15, 2028."}],"balance_after":175000,"derivative":{"exercise_price":2.38,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000950170-24-016464","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563880/000095017024016464/ownership.xml","form_type":"4"}},{"id":2117492,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":94207,"kind":"person","name":"Clark David J","position":1,"cik":"0001662693","reported_name":"Clark David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-14T21:43:53.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on November 14, 2022. The 300,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on November 14, 2023 and as to the remaining 75% of the shares in equal monthly installments thereafter, through November 14, 2026."}],"balance_after":300000,"derivative":{"exercise_price":2.02,"expiration_date":"2032-11-13","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-22-056635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563880/000120919122056635/doc4.xml","form_type":"4"}},{"id":3418401,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":94207,"kind":"person","name":"Clark David J","position":1,"cik":"0001662693","reported_name":"Clark David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-09-10T21:01:08.000Z","date":"2019-09-06","kind":"purchase","acquired":true,"shares":5000,"price":5.0622,"value":25311.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,366 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2019."}],"balance_after":17878,"source":{"system":"sec-edgar","filing":"0000899243-19-023265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924319023265/doc4.xml","form_type":"4"}},{"id":3605875,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":94207,"kind":"person","name":"Clark David J","position":1,"cik":"0001662693","reported_name":"Clark David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-07T22:22:28.000Z","date":"2019-03-05","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2019."}],"balance_after":250000,"derivative":{"exercise_price":8.05,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-19-006730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924319006730/doc4.xml","form_type":"4"}},{"id":3605874,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":94207,"kind":"person","name":"Clark David J","position":1,"cik":"0001662693","reported_name":"Clark David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-07T22:22:28.000Z","date":"2019-03-05","kind":"grant","acquired":true,"shares":3503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2019, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,235 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2018."}],"balance_after":11512,"source":{"system":"sec-edgar","filing":"0000899243-19-006730","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924319006730/doc4.xml","form_type":"4"}},{"id":4005036,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":94207,"kind":"person","name":"Clark David J","position":1,"cik":"0001662693","reported_name":"Clark David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-08T21:40:08.000Z","date":"2018-03-06","kind":"grant","acquired":true,"shares":108633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2018."}],"balance_after":108633,"derivative":{"exercise_price":8.6,"expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":108633},"source":{"system":"sec-edgar","filing":"0000899243-18-006818","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924318006818/doc4.xml","form_type":"4"}},{"id":4005035,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":94207,"kind":"person","name":"Clark David J","position":1,"cik":"0001662693","reported_name":"Clark David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-08T21:40:08.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":4774,"price":3.995,"value":19072.13,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the voluntary reporting of 4,774 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in December 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the voluntary reporting of 4,774 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in December 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 3, 2017."}],"balance_after":4774,"source":{"system":"sec-edgar","filing":"0000899243-18-006818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924318006818/doc4.xml","form_type":"4"}},{"id":4396872,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":94207,"kind":"person","name":"Clark David J","position":1,"cik":"0001662693","reported_name":"Clark David J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-07T22:45:36.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":155656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2017."}],"balance_after":155656,"derivative":{"exercise_price":5.1,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":155656},"source":{"system":"sec-edgar","filing":"0000899243-17-006713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000089924317006713/doc4.xml","form_type":"4"}}]}